- Separation of antibody variants based on differences in net charge.
- Detection and quantification of acidic, main, and basic species.
- Assessment of how processing, storage, or formulation conditions influence isoform distribution.
Antibody Isoform & Charge Variant Evaluation Service
Introduction
Antibodies frequently exist as heterogeneous populations due to variations in post-translational modifications, glycosylation, deamidation, C-terminal lysine processing, and other microheterogeneities. These variants, often referred to as isoforms or charge variants, can significantly impact stability, solubility, binding kinetics, and efficacy in downstream applications. Accurate characterization and quantification of isoform and charge variant distributions are essential for quality control, batch consistency, and the design of stable antibody formulations.
The Antibody Isoform & Charge Variant Evaluation Service provides a comprehensive, multi-platform assessment of antibody heterogeneity, offering both qualitative and quantitative insights. By combining ion-exchange chromatography, capillary isoelectric focusing, mass spectrometry, and complementary biophysical techniques, we provide detailed mapping of isoform profiles and their functional implications. This enables scientists and developers to understand how structural microheterogeneity may affect performance, optimize production processes, and ensure reliable experimental outcomes.
Strategies
Cation and Anion Exchange Chromatography (CEX/AEX)
Capillary Isoelectric Focusing (cIEF)
- High-resolution separation based on isoelectric point (pI).
- Sensitive detection of subtle charge shifts caused by deamidation, glycation, or lysine clipping.
- Provides reproducible profiling suitable for batch-to-batch comparison.
Mass Spectrometry (MS)
- Intact MS to resolve isoforms differing in mass due to glycosylation or terminal modifications.
- Subunit and peptide-level MS for detailed mapping of charge-affecting PTMs.
- Quantitative comparison against theoretical isoform distribution for verification of production consistency.
Biolayer Interferometry (BLI)
- Functional assessment to determine if identified isoforms affect antigen binding kinetics.
- Parallel evaluation of multiple isoform fractions to correlate charge variants with functional changes.
Orthogonal Interpretation
- Integration of chromatographic, electrophoretic, mass, and functional data provides a holistic view of antibody heterogeneity.
- Highlights potential stability or solubility risks associated with specific isoforms.
- Enables optimization of purification strategies, formulation buffers, and storage conditions to minimize undesirable variants.
By combining structural and functional insights, this service ensures a clear understanding of how isoforms and charge variants influence antibody quality and performance.
Required Materials
Clients should provide the following materials for effective isoform and charge variant evaluation:
-
Antibody Samples
- Recommended concentration: 1–5 mg/mL for monoclonal antibodies.
- Minimum volume: 200–500 µL per antibody. Higher volume may be required if fractionation for functional assays is planned.
-
Buffer and Formulation Information
- Complete buffer composition, pH, ionic strength, and any excipients or stabilizers present.
-
Sequence or Reference Data
- Annotated sequence, expected pI, or known isoform information to guide analysis.
-
Target Antigen (for BLI assays)
- Purified antigen or peptide for functional assessment of variant fractions.
-
Project Brief
- Specific goals (e.g., batch comparison, process optimization, formulation development) and known issues.
Properly labeled samples and cold shipment help maintain integrity during transport.
Publications
Isoform and charge variant analysis is a well-established component of antibody characterization and is referenced extensively in the literature:
These studies validate the use of CEX, cIEF, MS, and functional assays to comprehensively profile antibody isoforms and charge variants.
FAQs
Why is charge variant analysis important?
Charge variants can affect antibody solubility, stability, and binding kinetics. Understanding the distribution of acidic, main, and basic species informs formulation, purification, and storage strategies.
How are isoforms detected?
Isoforms are detected using complementary approaches: CEX/AEX for net charge, cIEF for high-resolution pI profiling, and MS for mass differences arising from glycosylation or terminal modifications.
Can these variants affect function?
Yes. Certain isoforms may have altered antigen binding kinetics or reduced thermal stability. BLI allows correlation between structural heterogeneity and functional impact.
What is the typical sample requirement?
200–500 µL at 1–5 mg/mL is recommended, but smaller volumes can be accommodated for focused studies.
How long does the analysis take?
Standard turnaround is 12–18 business days, depending on the number of antibodies and complexity of isoform profiles.
Can this service support batch-to-batch consistency monitoring?
Yes. Reproducible CEX, cIEF, and MS profiles allow quantitative comparison between production lots, aiding in quality control and process optimization.
Contact Us
Ensure reliable characterization of antibody isoforms and charge variants with our Antibody Isoform & Charge Variant Evaluation Service. Our experts combine CEX/AEX, cIEF, MS, and BLI techniques to deliver detailed structural and functional insights that guide purification strategies, formulation design, and stability assessments.
To discuss your project, submit samples, or request a customized evaluation plan, please contact our team. Provide antibody sequence, formulation details, and any reference batch information for a tailored, high-resolution assessment of isoform distribution and functional impact.
For research use only. Not intended for any clinical use.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
